United States Patent and Trademark Office, Patent Assignment 64487/149:
Assignment Of Assignors Interest
Assignors
Assignee
Lee, Sang Don
Paperwork Executed March 27, 2023
Kim, Jeong A
Paperwork Executed March 31, 2023
Lee, Sang Hyun
Paperwork Executed March 31, 2023
Lee, Jong-soo
Paperwork Executed March 31, 2023
Recorded
August 3, 2023
Hanmi Pharm Company, Ltd.
Officially Listed As "Hanmi Pharm. Company, Ltd."
Hanmi Pharm Company, Ltd.
550, Dongtangiheung-ro, Hwaseong-si
Gyeonggi-do
SOUTH KOREA
Patents
Correspondent
Therapeutic Use Of Long-acting Conjugate Of Triple Agonist Acting On All Of Glucagon, Glp-1 And Gip Receptors Against Multiple Sclerosis
X0 Patent Application No. 18028348 , Filed March 24, 2023
A1 Application Publication No. 20230372448, Issued November 23, 2023
Sughrue Mion, PLLC
2000 Pennsylvania Ave Nw Ste 900
Washington, DC 200061812
Updated November 23, 2023
View this assignment via USPTO Assignments on the Web
Statistics
This assignment has been viewed 0 times.
Information Facts
https://www.plainsite.org/patents/assignment.html?id=11459119
Primary Sources
Government agencies: SEC/EDGAR, federal and state courts, USPTO, IRS, and others
AI text generation None
AI document summarization None
AI-augmented search None
AI-generated images None
AI chat or Q&A interface Linkable via MCP
Third party AI contribution in government documents Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.